Gautam Mehta, Su Lin, Aida Nadar, Bharadwaj Pv, Ravi Kumar, Anu Balaji, Stewart Macdonald, Mohammed F Sheikh, MohammadMahdi Saeidinejad, Shiv-Raj Sharma, Ji J King, Rajeshwar P Mookerjee, Lorraine McDonagh, Sarah A Afuwape, Kevin Moore, Rajiv Jalan
BACKGROUND & AIMS: Maintenance of abstinence in alcohol-related liver disease (ARLD) is a major unmet therapeutic need. Digital therapeutics can deliver ongoing behavioural therapy, in real-time, for chronic conditions. The aim of this project was to develop and clinically test AlcoChange, a novel digital therapeutic for ARLD. METHODS: AlcoChange was developed using validated behaviour change techniques and a digital alcohol breathalyser. This was an open-label, single-centre study...
April 2024: JHEP reports: innovation in hepatology